{
  "pmcid": "10850618",
  "sha256": "ab55f5af62287d523ee59f496bc121752caf603f0ba852857a717281d13769c1",
  "timestamp_utc": "2025-11-09T15:12:38.711680+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.996883116883119,
    "reading_ease": 47.00818181818184,
    "word_count": 242
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This randomized trial of short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE)"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomization was performed centrally through a web-based system."
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients treated for cerebral aneurysm with SACE were enrolled from 17 hospitals in Japan."
      },
      "Intervention": {
        "score": 2,
        "evidence": "assigned in a 1:1 ratio to receive long-term (12 months) or short-term (3 months) DAPT with aspirin and clopidogrel."
      },
      "Objective": {
        "score": 1,
        "evidence": "aimed to clarify whether long-term DAPT can reduce the occurrence of ischemic stroke in patients with cerebral aneurysms treated by SACE compared with short-term DAPT."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the time to ischemic stroke event during 3 to 12 months after SACE."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomization was performed centrally through a web-based system."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 142 patients were recruited from November 4, 2016 to January 7, 2019."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "65 and 68 patients assigned to the long- and short-term DAPT groups, respectively, were included in the full analysis set."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The incidence rate did not differ between the groups (0.0 vs 2.1/100 person-years; log rank test, P=0.33)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "This trial was registered with the Japan Registry of Clinical Trials (jRCTs051180141)."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}